Mode
Text Size
Log in / Sign up

Heart Failure

164 published articles · Updated continuously

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Questions about Heart Failure

Are SGLT2 inhibitors effective for treating heart failure with mildly reduced ejection fraction?

Yes, SGLT2 inhibitors are effective for treating heart failure with mildly reduced ejection fraction, reducing heart failure hospitalizations and improving outcomes.

Full answer →
Does finerenone help patients with heart failure with mildly reduced ejection fraction?

Yes, finerenone reduces cardiovascular death and worsening heart failure events in patients with heart failure with mildly reduced ejection fraction, based on a network meta-analysis and the FINEARTS-HF trial.

Full answer →
Can erythropoiesis-stimulating agents help adults with chronic heart failure and anaemia?

Erythropoiesis-stimulating agents (ESAs) reduce total heart failure hospitalizations and improve exercise tolerance in adults with chronic heart failure and anaemia, but do not lower mortality risk.

Full answer →
Do alternative loop diuretics reduce hospitalizations for patients with chronic heart failure?

No, alternative loop diuretics (torsemide, azosemide, piretanide) do not reduce hospitalizations compared to furosemide in chronic heart failure, based on a systematic review of 23 trials.

Full answer →
What are the main themes in coping experiences for chronic heart failure patients and caregivers?

Coping experiences for CHF patients and caregivers center on differing views of illness, emotional exhaustion, strained relationships, and a need for support to find new meaning.

Full answer →
Does taking Qishen Yiqi dropping pills plus Western medicine improve chronic heart failure efficacy?

A 2024 trial found that adding Qishen Yiqi dropping pills to standard Western medicine improved clinical effectiveness and heart function in chronic heart failure patients.

Full answer →
Does having higher levels of EPA in my blood increase my risk of ischemic heart disease?

Higher EPA levels may slightly increase ischemic heart disease risk, according to genetic studies, but the evidence is not definitive.

Full answer →
What side effects or benefits did levosimendan show for patients with acute heart failure?

Levosimendan improves symptoms and heart function in acute heart failure, but can cause hypotension and tachycardia; benefits may vary by BMI.

Full answer →
See all 20 questions about Heart Failure →